JOURNAL ARTICLE

Study Results from Ningbo No. 2 Hospital Update Understanding of Parkinson's Disease (Branched-chain amino acids and the risks of dementia, Alzheimer's disease, and Parkinson's disease).

  • Published In: Mental Health Weekly Digest, 2024. P. 714 1 of 2

  • Database: Psychology Source 2 of 2

Abstract

A recent study conducted at Ningbo No. 2 Hospital in China explored the association between blood levels of branched-chain amino acids (BCAAs) and the risk of developing neurodegenerative disorders such as dementia, Alzheimer's disease (AD), and Parkinson's disease (PD). The study analyzed data from the UK Biobank and found that higher levels of isoleucine, leucine, and valine were associated with a reduced risk of dementia and AD. However, higher levels of isoleucine and leucine were linked to an increased risk of PD, although this correlation may be influenced by other factors. The study suggests that BCAAs could potentially serve as biomarkers for dementia and AD, but further research is needed to understand the underlying mechanisms. [Extracted from the article]

Additional Information

  • Source:Mental Health Weekly Digest. 2024/04, p714
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2024
  • ISSN:1543-6616
  • Accession Number:176676237
  • Copyright Statement:Copyright of Mental Health Weekly Digest is the property of NewsRx and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.